Adenocarcinoma Clinical Trials Adenocarcinoma RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
Conditions: Gastric Cancer; Gastroesophageal Junction Cancer Interventions: Drug: AZD0901; Drug: AZD0901; Drug: Ramucirumab+ paclitaxel; Drug: Paclitaxel; Drug: Docetaxel; Drug: Irinotecan; Drug: TAS-102; Drug: Apatinib Sponsors: AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials

A 3-Arm Study Comparing the Efficacy of Anti-Reflux Reconstruction Protocols After Laparoscopic Proximal Gastrectomy
Conditions: Anti-Reflux Alimentary Reconstruction; Laparoscopic Proximal Gastrectomy; Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Interventions: Procedure: Anti-Reflux Alimentary Reconstruction After Laparoscopic Proximal Gastrectomy Sponsors: Northern Jiangsu People ' s Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials

PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study)
Conditions: Pancreatic Ductal Adenocarcinoma Interventions: Radiation: Radiotherapy; Drug: Immunotherapy:Granulocyte macrophage-colony stimulating factor(GM-CSF) 、Cadumilimab; Drug: Chemotherapy:Albumin-bound paclitaxel、Gemcitabine Sponsors: Second Affiliated Hospital of Soochow University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials

Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma
Conditions: Pancreatic Ductal Adenocarcinoma Interventions: Other: potential predictors Sponsors: Fudan University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials

Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas
Conditions: Gastric Cancer; MSI-H; Metastatic Cancer; Advanced Cancer Interventions: Drug: Balstilimab; Drug: Botensilimab; Drug: Folfox Protocol; Drug: XELOX; Drug: Nivolumab Sponsors: Centre Leon Berard; Agenus Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials

A Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma
Conditions: Gastric and Gastroesophageal Junction Adenocarcinoma Interventions: Drug: cadonilimab; Drug: pulocimab; Drug: paclitaxel; Drug: placebo Sponsors: Akeso Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

Stomach Cancer Exosome-based Detection
Conditions: Gastric Cancer; Gastric Adenocarcinoma; Gastric Cancer Stage; Gastric Neoplasm; Gastric Lesion; Gastric Cancer in Situ; Gastric Cancer Stage IV; Gastric Cancer Stage IIIB; Gastric Cancer Stage III; Gastric Cancer Stage IB; Gastric Cancer Stage IA; Gastric Cancer, Stage 0; Gastric Cancer Stage IIIA; Gastric Cancer Stage II; Gastric Cancer TNM Staging; Gastric Cancer Metastatic to Lung; Gastric Cancer Metastatic to Liver; Gastric Cancer Stage I; Gastric Cancer TNM Staging Primary Tumor (T) T2B Interventions: Diagnostic Test: DESTINEX Sponsors: City of Hope Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

Early Onset Colorectal Cancer Detection
Conditions: Colorectal Cancer; Colorectal Neoplasms; Colorectal Adenocarcinoma; Colorectal Cancer Stage I; Colorectal Cancer Stage IV; Colorectal Cancer Stage II; Colorectal Cancer Stage III; Colorectal Neoplasms Malignant Interventions: Diagnostic Test: ENCODE Sponsors: City of Hope Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

EUS Role in Non-metastatic Pancreatic Adenocarcinoma Lymph Nodes Staging
Conditions: Pancreatic Adenocarcinoma; Lymph Node Metastasis Interventions: Other: malignant lymph nodes Sponsors: Paolo Giorgio Arcidiacono, MD Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

Early Detection of Advanced Adenomas and Colorectal Cancer
Conditions: Colorectal Cancer; Colorectal Neoplasms; Colorectal Polyp; Colorectal Adenocarcinoma; Colorectal Disorders; Colorectal Dysplasia; Colorectal Cancer Stage I; Colorectal Cancer Stage II; Colorectal Cancer Stage III; Colorectal Cancer Stage IV; Colorectal Neoplasms Malignant; Colorectal Serrated Adenocarcinoma; Colorectal Adenoma With Severe Dysplasia; Colorectal Adenoma With Mild Dysplasia; Colorectal Adenoma With Moderate Dysplasia; Colorectal Adenoma and Carcinoma 1; Colorectal Adenomatous Polyp; Colorectal Adenocarcinoma Metastatic in the Liver Interventions: Diagnostic Test: DENEB Sponsors: City of Hope Medic...
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201
Conditions: Breast Cancer; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma Interventions: Drug: AB-201; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors: GC Cell Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

Analysis of Histopathological Factors Predictive of Lymph Node Involvement and Management Practices in pT1 Colorectal Cancers Treated by Primary Endoscopic Resection: a Retrospective Population-based Study (PROMOT1)
Conditions: Colorectal Cancer; Colorectal Adenocarcinoma Sponsors: University Hospital, Brest Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials

Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Conditions: Esophageal Adenocarcinoma; Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma Interventions: Drug: OBP-301; Drug: Pembrolizumab Sponsors: Weill Medical College of Cornell University; Merck Sharp& Dohme LLC; Oncolys BioPharma Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials

A Novel Online Calculator to Predict Long-term Survival and Recurrence Risk of Patients With Gastric Adenocarcinoma
Conditions: Gastric Cancer Sponsors: Fujian Medical University; Fujian Medical University Union Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials

A Deep Learning Radiomics Model for Predicting Occult Peritoneal Metastases of Pancreatic Adenocarcinoma
Conditions: Pancreatic Neoplasms Interventions: Procedure: surgery or diagnostic staging laparoscopy Sponsors: First Affiliated Hospital, Sun Yat-Sen University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials